107 related articles for article (PubMed ID: 9221278)
1. Vascular aldosterone. Biosynthesis and a link to angiotension II-induced hypertrophy of vascular smooth muscle cells.
Gómez-Sánchez EP
J Endocrinol Invest; 1995; 18(7):580-5. PubMed ID: 9221278
[No Abstract] [Full Text] [Related]
2. Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells.
Hatakeyama H; Miyamori I; Fujita T; Takeda Y; Takeda R; Yamamoto H
J Biol Chem; 1994 Sep; 269(39):24316-20. PubMed ID: 7929089
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of D3 dopamine receptor on migration of vascular smooth muscle cells induced by synergistic effect of angiotensin II and aldosterone.
Li Y; Wang N; Chen C; He D; Yang J; Zeng C
Clin Exp Hypertens; 2015; 37(4):288-93. PubMed ID: 25496286
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone and vascular damage.
Duprez D; De Buyzere M; Rietzschel ER; Clement DL
Curr Hypertens Rep; 2000 Jun; 2(3):327-34. PubMed ID: 10981167
[TBL] [Abstract][Full Text] [Related]
5. Role of the lipoxygenase pathway in angiotensin II-induced vascular smooth muscle cell hypertrophy.
Natarajan R; Gonzales N; Lanting L; Nadler J
Hypertension; 1994 Jan; 23(1 Suppl):I142-7. PubMed ID: 8282345
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
Jaffe IZ; Mendelsohn ME
Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells.
Berk BC; Vekshtein V; Gordon HM; Tsuda T
Hypertension; 1989 Apr; 13(4):305-14. PubMed ID: 2466788
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells.
Mazak I; Fiebeler A; Muller DN; Park JK; Shagdarsuren E; Lindschau C; Dechend R; Viedt C; Pilz B; Haller H; Luft FC
Circulation; 2004 Jun; 109(22):2792-800. PubMed ID: 15159288
[TBL] [Abstract][Full Text] [Related]
9. Arginine vasopressin-induced hypertrophy of cultured rat aortic smooth muscle cells.
Geisterfer AA; Owens GK
Hypertension; 1989 Oct; 14(4):413-20. PubMed ID: 2793215
[TBL] [Abstract][Full Text] [Related]
10. Arachidonic acid metabolites mediate angiotensin II-induced NADH/NADPH oxidase activity and hypertrophy in vascular smooth muscle cells.
Zafari AM; Ushio-Fukai M; Minieri CA; Akers M; Lassègue B; Griendling KK
Antioxid Redox Signal; 1999; 1(2):167-79. PubMed ID: 11228745
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone mediates angiotensin II-stimulated rat vascular smooth muscle cell proliferation.
Xiao F; Puddefoot JR; Vinson GP
J Endocrinol; 2000 May; 165(2):533-6. PubMed ID: 10810318
[TBL] [Abstract][Full Text] [Related]
12. Deletion of the EGF receptor in vascular smooth muscle cells prevents chronic angiotensin II-induced arterial wall stiffening and media thickening.
Schreier B; Hünerberg M; Mildenberger S; Rabe S; Bethmann D; Wickenhauser C; Gekle M
Acta Physiol (Oxf); 2018 Mar; 222(3):. PubMed ID: 29152859
[TBL] [Abstract][Full Text] [Related]
13. Novel role of protein kinase C-delta Tyr 311 phosphorylation in vascular smooth muscle cell hypertrophy by angiotensin II.
Nakashima H; Frank GD; Shirai H; Hinoki A; Higuchi S; Ohtsu H; Eguchi K; Sanjay A; Reyland ME; Dempsey PJ; Inagami T; Eguchi S
Hypertension; 2008 Feb; 51(2):232-8. PubMed ID: 18180404
[TBL] [Abstract][Full Text] [Related]
14. Effects of an angiotensin II receptor antagonist, CV-11974, on angiotensin II-induced increases in cytosolic free calcium concentration, hyperplasia, and hypertrophy of cultured vascular smooth muscle cells.
Koh E; Morimoto S; Tomita J; Rakugi H; Jiang B; Inoue T; Nabata T; Fukuo K; Ogihara T
J Cardiovasc Pharmacol; 1994 Feb; 23(2):175-9. PubMed ID: 7511744
[TBL] [Abstract][Full Text] [Related]
15. The expression of steroidogenic enzyme genes in human vascular cells.
Hatakeyama H; Miyamori I; Takeda Y; Yamamoto H; Mabuchi H
Biochem Mol Biol Int; 1996 Oct; 40(3):639-45. PubMed ID: 8908375
[TBL] [Abstract][Full Text] [Related]
16. ADAM17 mediates epidermal growth factor receptor transactivation and vascular smooth muscle cell hypertrophy induced by angiotensin II.
Ohtsu H; Dempsey PJ; Frank GD; Brailoiu E; Higuchi S; Suzuki H; Nakashima H; Eguchi K; Eguchi S
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):e133-7. PubMed ID: 16840716
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.
Montezano AC; Callera GE; Yogi A; He Y; Tostes RC; He G; Schiffrin EL; Touyz RM
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1511-8. PubMed ID: 18467645
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of epigallocatechin 3-O-gallate on vascular smooth muscle cell hypertrophy induced by angiotensin II.
Zheng Y; Song HJ; Kim CH; Kim HS; Kim EG; Sachinidis A; Ahn HY
J Cardiovasc Pharmacol; 2004 Feb; 43(2):200-8. PubMed ID: 14716206
[TBL] [Abstract][Full Text] [Related]
19. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats.
Peiró C; Llergo JL; Angulo J; López-Novoa JM; Rodríguez-López A; Rodríguez-Mañas L; Sánchez-Ferrer CF
Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925
[TBL] [Abstract][Full Text] [Related]
20. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy.
Zafari AM; Ushio-Fukai M; Akers M; Yin Q; Shah A; Harrison DG; Taylor WR; Griendling KK
Hypertension; 1998 Sep; 32(3):488-95. PubMed ID: 9740615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
